TNFRSF1A and COVID-19: However, although anti-TNF therapy is used in many inflammatory diseases, for the context of COVID-19 the findings related to TNF level are unclear, and the information regarding TNFR levels among the patients of COVID-19 is scarce, indicating that more studies are necessary to consider anti-TNF therapy in COVID-19 patients.